The effect of single administration of alpha-glucosidase inhibitors or sitagliptin on glucose metabolism and gut-derived hormones

Trial Profile

The effect of single administration of alpha-glucosidase inhibitors or sitagliptin on glucose metabolism and gut-derived hormones

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2014

At a glance

  • Drugs Miglitol (Primary) ; Acarbose; Sitagliptin
  • Indications Type 2 diabetes mellitus
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 06 Aug 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 06 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top